Product Details



OSTEOARTHRITIS THERAPEUTICS MARKET - GLOBAL FORECAST TO 2024

Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) & Region - Global Forecast to 2024



The Osteoarthritis Therapeutics market, in terms of value, is projected to grow at a CAGR of XX% from 2019 to 2024. The market is estimated to be USD XX Billion in 2019, and is projected to reach XX Billion by 2024. In this study, 2018 has been considered the base year, and 2019 to 2024 the forecast period, for estimating the market size of the global market.

OBJECTIVES OF THE STUDY

  • To define, describe, and forecast the Osteoarthritis Therapeutics market segmented by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) & Region
  • To forecast the market size in terms of value for various segments with respect to four main regions: North America, Europe, APAC, Latin America and Middle East & Africa
  • To provide detailed information regarding the major factors influencing the growth of the Osteoarthritis Therapeutics market (drivers, restraints, opportunities, and industry-specific challenges)
  • To provide a detailed overview of the value chain in the Osteoarthritis Therapeutics market and analyze the market trends with Porter’s five forces analysis
  • To analyze the opportunities in the market for various stakeholders by identifying the high-growth segments of the Osteoarthritis Therapeutics market
  • To strategically profile the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
  • To analyze competitive developments such as new product launches and developments; agreements and contracts; mergers and acquisitions; and expansions in the global Osteoarthritis Therapeutics market

Scope of the Report:

Market, by Anatomy

Knee

Hip

Hand

Small Joints (Foot & Ankle and Wrist )

Market, by Drug Type

Viscosupplementation Agents

Nonsteroidal Anti-inflammatory Drugs

Analgesics

Corticosteroids

Market, by Route of Administration

Parenteral

Topical

Oral

Market, by Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Market, by Purchasing Pattern

Prescription Drug

Over-the-counter Drug

Based on the region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1 Introduction

2 Research Methodologies

3 Executive Summaries 

4 Premium Insights
    4.1 Osteoarthritis Therapeutics Market Overview
    4.2 Osteoarthritis Therapeutics Market, By Anatomy
    4.3 Osteoarthritis Therapeutics Market, By Drug Type
    4.4 Osteoarthritis Therapeutics Market, By Route of Administration
    4.5 Osteoarthritis Therapeutics Market, By Distribution Channel
    4.6 Osteoarthritis Therapeutics Market, By Purchasing Pattern
    4.7 Osteoarthritis Therapeutics Market, By Region

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 Osteoarthritis Therapeutics Market, By Anatomy
    6.1 Introduction
    6.2 Knee Osteoarthritis
    6.3 Hip Osteoarthritis
    6.4 Hand Osteoarthritis
    6.5 Small-Joint Osteoarthritis

7 Osteoarthritis Therapeutics Market, By Drug Type
    7.1 Introduction
    7.2 Viscosupplementation Agents
    7.3 Nonsteroidal Anti-Inflammatory Drugs
                    7.3.1.1 Ibuprofen
                    7.3.1.2 Diclofenac
                    7.3.1.3 Aspirin
                    7.3.1.4 Naproxen
                    7.3.1.5 Other Molecules
    7.4 Analgesics
           7.4.1 Acetaminophen
           7.4.2 Duloxetine
    7.5 Corticosteroids

8 Osteoarthritis Therapeutics Market, By Route of Administration
    8.1 Introduction
    8.2 Oral Route
    8.3 Parenteral Route
    8.4 Topical Route

9 Osteoarthritis Therapeutics Market, By Distribution Channel
    9.1 Introduction
    9.2 Hospital Pharmacies
    9.3 Online Pharmacies
    9.4 Retail Pharmacies

10 Osteoarthritis Therapeutics Market, By Purchasing Pattern
     10.1 Introduction
     10.2 Prescription Drugs
     10.3 Over-The-Counter Drugs

11 Osteoarthritis Therapeutics Market, By Region
     11.1 Introduction
     11.2 Europe
     11.3 North America
     11.4 Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape

13 Company Profiles
     (Business Overview, Financials, Products Offered, Recent Developments)*
     13.1 Sanofi
     13.2 Horizon Therapeutics PLC
     13.3 Johnson & Johnson
     13.4 Glaxosmithkline PLC
     13.5 Bayer AG
     13.6 Abbott
     13.7 Pfizer, Inc.
     13.8 Eli Lilly
     13.9 Anika Therapeutics, Inc.
     13.10 Novartis
     13.11 Ferring Pharmaceuticals
     13.12 Bioventus
     13.13 Zimmer Biomet Holdings, Inc.
     13.14 Fidia Farmaceutici S.P.A.
     13.15 Flexion Therapeutics, Inc.

 *Details Might Not Be Captured in Case of Unlisted Companies.

Single User   1530.00

Multiple User   2200.00
Latest Product